Diagnostic Products

Cancer diagnostics & monitoring

Next-generation sequencing (NGS) continues to evolve yet challenges exist. We are developing in vitro diagnostics (IVDs) and Personalized Cancer Monitoring (PCM™) for solid tumor biomarker identification.

Our products in development include

In Vitro Diagnostics

ArcherDX is developing a new solid tumor IVD designed to identify actionable genomic alterations in tissue and blood samples that is intended for use as a companion diagnostic. The panel has received two Breakthrough Device Designations from the U.S. FDA.

Personalized Cancer Monitoring

ArcherDX is developing Personalized Cancer Monitoring (PCM™) panels that are patient-specific, highly sensitive and minimally invasive liquid biopsy tests intended for monitoring early-stage cancer treatment and recurrence.